Product peg-derivatives -peptide-pegs

Home > products > peg-derivatives > peptide-pegs

Catalog	name	Description	price
R-M2-9303	Cholesterol-PEG2000-mal-C-LNSSQPS-C-K-FITC	Cholesterol-PEG2000-mal-C-LNSSQPS-C-K-FITC was used in biological studies for imaging, drug delivery, or targeted therapies.	price>
R-M2-9362	SH-PEG2000-SP94	SH-PEG2000-SP94(SFSIIHTPILPL) might be employed in targeted drug delivery systems, bioconjugation strategies, or in biotechnological applications aimed at enhancing the properties or functions of the molecules involved.	price>
R-M2-9371	Chol-PEG2K-GPLGVRG-PEG5K	Chol-PEG2K-GPLGVRG-PEG5K can be used in drug delivery systems, biomaterials, or for modifying the properties of biomolecules for various applications in biotechnology and pharmaceuticals.	price>
R-M2-9372	HYD-PEG2000-Peptide(CKIGLFRWR)	Hydrazide-PEG2000-Peptide(CKIGLFRWR) { PEG and peptide linkage method is MAL-SH} can be utilized in bioconjugation chemistry, drug delivery systems, and other applications in biotechnology and medicine.	price>
R-M2-9380	DMG-PEG2000-cRGDfk	DMG-PEG2000-cRGDfk represents a multifunctional compound that is tailored for applications in targeted drug delivery, potentially in cancer therapy. By incorporating a lipid component (DMG), a hydrophilic polymer (PEG), and a targeting peptide (cRGD), this conjugate is designed to improve the specificity and effectiveness of therapeutic agents.	price>
R-M2-9391	PEG2K-GGS-GPLGIAGQ-SGG-DSG	PEG2K-GGS-GPLGIAGQ-SGG-DSG is a peptide or protein construct . This construct may be a candidate for drug delivery systems or protein therapeutics, aimed at increasing half-life and reducing immune response. The design may facilitate studies in protein-protein interactions, assays, or as a molecular probe targeting specific cell types. The design of peptides and proteins often focuses on achieving specific biological effects while minimizing unwanted interactions.	price>
R-M2-9407	NHS-PEG2K-RRRRRRRR	NHS-PEG2K-RRRRRRRR/N-hydroxysuccinimide-PEG2K-RRRRRRRR is a multifunctional compound. At Drug Delivery Systems, it can improve the solubility and bioavailability of drugs while ensuring that they can effectively reach target cells. In terms of protein modification, through NHS-mediated conjugation, proteins can be modified for stability, activity enhancement, or ease of purification. In terms of Gene Therapy, the polyarginine sequence can facilitate the delivery of DNA or RNA into cells, improving transfection rates for therapeutic applications. It can be used in assays and imaging applications where specific binding or targeting is required.	price>
R-M2-9416	NH2-PEG-RGD	NH2-PEG-RGD/Amine-peg-RGD can be used for Targeted Drug Delivery, Cancer Therapy (RGD conjugates can specifically target tumor sites, enhancing the effectiveness of anti-cancer treatments while reducing systemic toxicity), Molecular Imaging, Diagnostics (RGD modified fluorescent probes can be used for the early detection of diseases based on cell adhesion properties) etc.	price>
R-M2-9426	Gly-Gly-Gly-PEG3-methyltetrazine	Site-Specific Labeling: The methyltetrazine can react with trans-cyclooctene (TCO) to form a stable covalent bond, making it useful for labeling biomolecules (e.g., proteins, antibodies) in a site-specific manner. This compound can be conjugated to fluorophores for imaging applications and tracking biomolecules in live cells. The PEG moiety improves the pharmacokinetic profile of drugs, while the peptide may provide targeting capabilities or facilitate cellular uptake. The addition of the methyltetrazine functionality allows for triggering drug release in response to specific biological targets or conditions. The methyltetrazine reactivity can be leveraged to create prodrugs that become activated in the presence of specific tumor markers or microenvironments. Gly-Gly-Gly-PEG3-methyltetrazine can be used to create bifunctional probes for studying interactions between proteins or other biomolecules.	price>
R-M2-9445	CSMAHPYFARC-PEG2000	The CSMAHPYFARC-PEG2000 conjugate can have various applications in scientific and biomedical research, including: Drug Delivery: The PEG component can improve the pharmacokinetics of the peptide, making it an attractive candidate for targeted drug delivery systems, particularly in cancer therapy or peptide-based drugs. Fluorescent Labeling: If this is part of a fluorescently labeled peptide strategy, it can be used in cellular studies to monitor peptide uptake and localization within cells. Diagnostic Tools: The peptide could be used in immunoassays or as part of a diagnostic probe, especially if the amino acid sequence corresponds to a specific biomarker or receptor. Therapeutic Peptide Research: The specific sequence may have bioactive properties, and conjugating with PEG would enhance its therapeutic potential while improving its pharmacodynamics.	price>

...